http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-343689-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40765ca9a78b54a8a76f781d159ad145
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
filingDate 2012-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_447e0fa2fc8f71b3468b49d3c568bec3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0624d9bda751e4c17924b93eadb49587
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f24af344aa1dd6cc56b04c70513df980
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76d96504a59e4cc1c000fe2a0c242eec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6c1530e1d0d9f209f7997857be877a8
publicationDate 2016-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-343689-B
titleOfInvention COMBINED FORMULATIONS OF DARUNAVIR.
abstract This invention relates to solid oral dosage forms of the darunavir HIV inhibitor and / or a pharmaceutically acceptable salt or solvate thereof, and combination formulations thereof.
priorityDate 2011-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID213039
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492200

Total number of triples: 30.